Astronics (ATRO) Q3 2024 earnings summary

Executive summary

• Sales increased 25% year-over-year in Q3 2024 to $203.7 million, reaching the highest level since Q1 2019, driven by strong Aerospace and Test Systems performance.

• Adjusted EBITDA rose 207% to $27.1 million, with adjusted net income of $12.2 million ($0.35/share); net loss narrowed to $11.7 million ($0.34/share), impacted by $7.0 million in refinancing costs.

• Bookings reached $189.2 million, with a backlog of $611.9 million and a book-to-bill ratio of 0.93 for the quarter.

• The company is transitioning CFO leadership, with Nancy Hedges set to succeed Dave Burney in January 2025.

• Significant legal and restructuring activities, including ongoing patent litigation and workforce alignment in Test Systems.

Financial highlights

• Gross margin improved to 21.0% in Q3 2024 (adjusted: 23.2%), up from 12.7% last year; gross profit was $42.7 million.

• Adjusted operating margin for Q3 2024 was 9.6%, with adjusted operating income of $19.6 million.

• Adjusted EBITDA margin expanded to 13.3% of sales for the quarter.

• Net debt at quarter-end was $174.6 million, up from $161.2 million at year-end 2023.

• Q3 2024 loss on extinguishment of debt was $7.0 million due to refinancing.

Outlook and guidance

• Q4 2024 sales expected between $190 million and $210 million; full-year 2024 revenue guidance raised to $777 million–$797 million, implying 14.2% growth at the midpoint.

• Management anticipates continued double-digit growth and margin improvement into 2025, though at a slower pace than 2024.

• Planned 2024 capital expenditures are $9 million–$11 million.

• Backlog entering Q4 stands at $611.9 million, significantly higher than historical levels.

• Restructuring in Test Systems segment expected to yield $2 million in annualized savings starting Q1 2025.